Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Akt: a key transducer in cancer
Pei‐Jane Tsai, Yi‐Hsin Lai, Rajesh Manne, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Antonino Glaviano, Aaron Song Chuan Foo, Hiu Yan Lam, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 737
Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents
Jingqian Su, Yingsheng Luo, Shan Hu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13381-13381
Open Access | Times Cited: 45
Kinase Inhibitors and Kinase-Targeted Cancer Therapies: Recent Advances and Future Perspectives
Jiahao Li, Gong Chen, Haiting Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5489-5489
Open Access | Times Cited: 21
The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer
Fabrizio Fontana, Gaia Giannitti, Sara Marchesi, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 8, pp. 3113-3125
Open Access | Times Cited: 21
PIK3CA mutation as an acquired resistance driver to EGFR-TKIs in non-small cell lung cancer: Clinical challenges and opportunities
Xiaohong Liu, Wuxuan Mei, Pengfei Zhang, et al.
Pharmacological Research (2024) Vol. 202, pp. 107123-107123
Open Access | Times Cited: 18
ALDH1L2 regulation of formate, formyl-methionine, and ROS controls cancer cell migration and metastasis
Marc Hennequart, Steven E. Pilley, Christiaan F. Labuschagne, et al.
Cell Reports (2023) Vol. 42, Iss. 6, pp. 112562-112562
Open Access | Times Cited: 23
Akt Inhibitor Advancements: From Capivasertib Approval to Covalent-Allosteric Promises
Kosmas Alexandros Pervanidis, G D'Angelo, Jörn Weisner, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6052-6063
Closed Access | Times Cited: 11
Targeting PI3K/AKT/mTOR Signaling to Overcome Drug Resistance in Cancer
Muhammad Tufail, Wendong Wan, Canhua Jiang, et al.
Chemico-Biological Interactions (2024) Vol. 396, pp. 111055-111055
Closed Access | Times Cited: 10
Decoding chemical profiles and biological activities of aerial parts and roots of Eryngium thorifolium Boiss by HPLC-MS/MS, GC-MS and in vitro chemical assays
Gokhan Zengin, Sakina Yagi, Omayma A. Eldahshan, et al.
Food Bioscience (2024) Vol. 61, pp. 104556-104556
Closed Access | Times Cited: 10
High-dose ascorbic acid synergizes with anti-PD1 therapy in non-small cell lung cancer in vitro and in vivo models
Hak Su Kim, Seunghyun Kwon, Ok Kyung Choi, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Structural Requirements of Isoform-Specific Inhibitors of Akt: Implications in the Development of Effective Cancer Treatment Strategies
Tenzin Adon, Syamal D. Bhattacharya, SubbaRao V. Madhunapantula, et al.
European Journal of Medicinal Chemistry (2025), pp. 117334-117334
Closed Access | Times Cited: 1
Computational drug repurposing of Akt-1 allosteric inhibitors for non-small cell lung cancer
Krishnaprasad Baby, Swastika Maity, Chetan Hasmukh Mehta, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 21
SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment
Ralf‐Peter Czekay, Craig E. Higgins, Hasan Basri Aydin, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 796-796
Open Access | Times Cited: 6
NLRP3-mediated autophagy dysfunction links gut microbiota dysbiosis to tau pathology in chronic sleep deprivation
Na Zhao, Chen Xiu, Qiu-Gu Chen, et al.
动物学研究 (2024) Vol. 45, Iss. 4, pp. 857-874
Open Access | Times Cited: 6
Advances in Melanoma: From Genetic Insights to Therapeutic Innovations
Fernando Valdez-Salazar, Luis Alberto Jiménez-Del Río, Jorge Ramón Padilla‐Gutiérrez, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1851-1851
Open Access | Times Cited: 6
SP1‐activated USP27X‐AS1 promotes hepatocellular carcinoma progression via USP7‐mediated AKT stabilisation
Su Chen, Haoquan Zhang, Jie Mo, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Unveiling the potential of FOXO3 in lung cancer: From molecular insights to therapeutic prospects
Mohammad Ebrahimnezhad, Amir Valizadeh, Maryam Majidinia, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116833-116833
Open Access | Times Cited: 5
Molecular pathways and targeted therapies in head and neck cancers pathogenesis
Marian Constantin, Mariana Carmen Chifiriuc, Coralia Bleoţu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Evaluation of the effect of GSK-3β on liver cancer based on the PI3K/AKT pathway
Jiageng Guo, Xinya Jiang, Jing Lian, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 4
Integrating network pharmacology to investigate the mechanism of quercetin's action through AKT inhibition in co-expressed genes associated with polycystic ovary syndrome and endometrial cancer
Mengyuan Li, Yewei Cui, Xue‐Ru Wu, et al.
International Journal of Biological Macromolecules (2025) Vol. 297, pp. 139468-139468
Closed Access
Immunomodulatory lectin from Cordia myxa targets PI3K/AKT signalling mediated apoptosis to regress both in-vitro and in-vivo tumour
B M Siddesh, Bayram Kıran, Ankith Sherapura, et al.
International Journal of Biological Macromolecules (2025) Vol. 294, pp. 139433-139433
Closed Access
Mechanism of Xin Sangqi Fuzheng Xiaoji Decoction in Liver Cancer Treatment: A Study Based on Network Pharmacology and in Vitro Experimental Validation
Yan Zhang, Ying-Di Qu, Chune Xie, et al.
(2025)
Closed Access
Anticancer and cancer preventive activities of shogaol and curcumin from Zingiberaceae family plants in KG-1a leukemic stem cells
Pawaret Panyajai, Natsima Viriyaadhammaa, Sawitree Chiampanichayakul, et al.
BMC Complementary Medicine and Therapies (2025) Vol. 25, Iss. 1
Open Access
Targeted Therapy: New Targets, Prospects and Clinical Use
Viktoriya R. Kuryanova, Feruza B. Guseinova, Aigerim E. Nurkeldina, et al.
Russian Journal of Oncology (2025)
Open Access
A Computational Journey in Anticancer Drug Discovery: Exploring AKT1 Inhibition by Novel Oxadiazoles Using Molecular Docking, ADMET, Density Functional Theory and Molecular Dynamic Simulation
Gauri alias Pooja M. Naik, Omkar Paradkar, Vishnu Dutt Sharma, et al.
Computational Biology and Chemistry (2025) Vol. 117, pp. 108425-108425
Closed Access
Page 1 - Next Page

Scroll to top